Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.110
0.00 (0.00%)
Aug 14, 2025, 11:16 AM - Market open
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $2.74 million as of August 14, 2025. Its market cap has decreased by -30.23% in one year.
Market Cap
2.74M
Enterprise Value
-1.65M
1-Year Change
-30.23%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $2.74M, a decrease of -99.98%. That is a compound annual growth rate of -83.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 2.74M | -24.73% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 589.99B |
| Johnson & Johnson | 418.55B |
| AbbVie | 356.67B |
| UnitedHealth Group | 246.80B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 224.87B |